Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000813300 | SCV000953657 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2020-12-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been shown to be highly prevalent in the general population and unaffected individuals (PMID: 26701604, 22335739). However, truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). This variant has not been reported in the literature in individuals with TTN-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the TTN gene (p.Lys3815Argfs*17). While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. |
Ai |
RCV002223250 | SCV002501271 | uncertain significance | not provided | 2022-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002478892 | SCV002779762 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV003237353 | SCV002817388 | likely pathogenic | Primary dilated cardiomyopathy | 2022-12-31 | criteria provided, single submitter | clinical testing |